Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever

dc.contributor.authorKaygusuz, Turkkan O.
dc.contributor.authorTartar, Ayse S.
dc.contributor.authorBalin, Safak O.
dc.contributor.authorAkbulut, Ayhan
dc.contributor.authorDemirdag, Kutbeddin
dc.date.accessioned2026-08-12T17:21:07Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: The aim of this study is to determine predictive parameters that can be used in the differential diagnosis of Crimean-Congo Hemorrhagic Fever (CCHF) and other diseases with similar clinical and laboratory findings. Materials & methods: In this study, epidemiological, clinical and laboratory parameters of 107 CCHF-positive and 71 CCHF-negative patients were compared. Results: Alanine amino transferase, aspartate aminotransferase, creatine kinase, lactate dehydrogenase, red blood cell, hemoglobin and hematocrit were significantly higher in CCHF-positive patients, whereas total and direct bilirubin, alkaline phosphatase, prothrombin time, international normalization ratio, white blood cell, C-reactive protein and procalcitonin were higher in CCHF-negative patients. In binary logistic regression analysis, an increase in activated partial thromboplastin time level was identified as an independent predictor of having CCHF, while alanine amino transferase, white blood cell and C-reactive protein elevations were identified as independent predictors of not having CCHF. Conclusion: In endemic areas where PCR and serological tests are delayed, knowing the predictive parameters may be of vital importance in the early diagnosis of CCHF.
dc.description.sponsorshipThe authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving
dc.description.sponsorshipThe authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.r The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.r No writing assistance was utilized in the production of this manuscript.r The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.
dc.identifier.doi10.2217/bmm-2023-0330
dc.identifier.endpage540
dc.identifier.issn1752-0363
dc.identifier.issn1752-0371
dc.identifier.issue11
dc.identifier.orcid0000-0003-2560-3265
dc.identifier.pmid37791843
dc.identifier.scopus2-s2.0-85175586637
dc.identifier.scopusqualityQ2
dc.identifier.startpage533
dc.identifier.urihttps://doi.org/10.2217/bmm-2023-0330
dc.identifier.urihttps://hdl.handle.net/11508/53822
dc.identifier.volume17
dc.identifier.wosWOS:001074831300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherFuture Medicine Ltd
dc.relation.ispartofBiomarkers in Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectclinic
dc.subjectCrimean-Congo hemorrhagic fever
dc.subjectepidemiological
dc.subjectlaboratory
dc.subjectparameters
dc.subjectpredictive
dc.titlePredictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever
dc.typeArticle

Dosyalar